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receptor (TNFR) family, based on limited sequence ho-
mology in its extracellular domain. It is expressed mainly
on mature B cells and possibly is induced in a subset
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costimulatory role for TACI in some aspect of B cell
growth or effector function; however, neither its true role
nor its endogenous ligand was known at the time (vonSummary
Bulow and Bram, 1997).
More recently, Gross et al. (2000) identified a ligandTACI is a TNFR homolog expressed by mature B lym-
for TACI as the B cell growth factor zTNF4. ZTNF4 is aphocytes that has been implicated in the positive regu-
member of the tumor necrosis factor family and waslation of B cell growth and antibody production, as
previously identified by several groups (synonyms in-well as in the development of autoimmune disease.
clude BLyS [Moore et al., 1999], BAFF [Schneider et al.,Its biology is complex due to the existence of two
1999], TALL-1 [Shu et al., 1999], THANK [Mukhopadhyayligands, BLyS and APRIL, and a homologous receptor,
et al., 1999], and TNFSF13b). This finding was consistentBCMA, that similarly binds both ligands. To determine
with the proposed role for BLyS, since it binds to matureits critical biological role, we generated TACI knockout
B cells and was known to selectively accelerate theirmice. Surprisingly, these mice demonstrated a 2-fold
growth. In addition, a distantly related TNFR familyincrease in numbers of circulating and splenic B cells,
member, BCMA, was identified by Gross et al. (2000)apparently due to increased proliferation rate. Matura-
as another B cell surface receptor able to bind to zTNF4.tion of B cells and T-dependent antibody production
The ability of BLyS to bind to TACI and/or BCMA haswas normal, but responses to T-independent type II
independently been shown by several investigatorsantigens were almost completely abolished. It appears
(Marsters et al., 2000; Shu and Johnson, 2000; Thomp-that TACI provides an essential costimulatory signal
son et al., 2000; Wu et al., 2000; Xia et al., 2000; Yan etfor the T-independent humoral response.
al., 2000). Interestingly, it was noted that stimulation
by BLyS, either in transgenic mice or by injection ofIntroduction
recombinant protein, induced increased numbers of B
cells and splenomegaly, as well as increased secretionAntibody production by B cells can be divided into
of antibodies and the production of autoantibodies lead-T-dependent and T-independent types. The former en-
ing to symptoms of systemic lupus erythematosus (SLE)compasses the response to most complex proteins. An
(Gross et al., 2000; Khare et al., 2000; Mackay et al.,essential component of the T-dependent response in-
1999). Conversely, the administration of soluble recom-cludes the costimulatory molecule CD40, which resides
binant TACI protein into mice inhibited antibody produc-on B cells and is activated by T cell-presented CD40L.
tion and the production of germinal centers in the spleenThis ensures appropriate T cell help, since CD40L is
(Yan et al., 2000). Gross et al. found that spontaneouslyupregulated following stimulation of the T cell receptor
autoimmune mice developed higher levels of circulating(TCR) (Foy et al., 1996; Laman et al., 1996). Certain bacte-
BLyS, raising the possibility that enhanced stimulationrial cell wall antigens, such as repeating polymers of
of TACI or BCMA may contribute to the disease. Injection
carbohydrates, however, are unable to stimulate such
of spontaneously autoimmune mice with soluble recom-
T/B cell interaction and activation. Nature’s answer to
binant TACI receptors suppressed kidney damage and
this deficiency appears in the form of a T-independent increased survival (Gross et al., 2000), implicating a role
antibody production response that involves the stimula- for this set of signaling molecules in autoimmunity. More
tion of B cells by antigen-presenting dendritic cells (Fa- recently, others have also reported elevated serum con-
garasan and Honjo, 2000). The details of the signals that centrations of soluble BLyS in humans with SLE (Zhang
regulate this capability are not completely understood, et al., 2001), thereby highlighting the relevance of these
but the importance of this mechanism is well known mouse models to human forms of autoimmune disease.
since it contributes significantly to the eradication of The situation has been complicated by recent reports
bacterial infections. Involvement of this system in the that indicate that another TNF family member, APRIL,
development of some types of autoimmune disease is able to bind to both BCMA and TACI with similar
(Fehr et al., 1997) further underscores the clinical impor- affinity (Marsters et al., 2000; Wu et al., 2000). Both
tance for understanding the details of its regulation. ligands (BLyS and APRIL) are able to compete with the
We previously cloned and characterized the gene en- other in binding to the TACI and BCMA receptors. In
coding the transmembrane activator and CAML inter- addition, there may be other, as yet undiscovered, li-
actor (TACI) protein by virtue of its ability to physically gands capable of binding to TACI and/or BCMA, or re-
interact with the CAML signal transduction protein. TACI ceptors for BLyS and APRIL. Thus, the precise contribu-
appears to be a member of the tumor necrosis factor tions to humoral immunity by the individual members of
this pathway are unclear. To more rigorously dissect the
biological role of TACI in B cell production and function,3 Correspondence: bram.richard2@mayo.edu)
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Figure 1. Targeting the taci Locus
(A) Targeting strategy for the taci locus show-
ing the restriction map (top) and the targeting
construct (bottom). Targeted exons 1 and 2
are boxed, and the direction of transcription
is indicated with an arrow. Location of probes
is indicated by XN and K. X, XmaI; N, NheI;
B, BglII; E, EcoRI; K, KpnI; H, HindIII; TK, Thy-
midine kinase cassette; and neo, G418-resis-
tance cassette.
(B) Southern blot of genomic DNA from 1/1
and 1/2 ES cells showing the targeted allele.
The left panel shows DNA from 1/1 and 1/2
ES cells digested with EcoRI and hybridized
with probe K. The right panel shows the same
DNA digested with XmaI and HindIII and hy-
bridized with probe XN.
(C) Southern blot of genomic DNA derived
from wild-type, heterozygous, and taci
knockout mice. Tail DNA was digested with
EcoR1 and hybridized with probe K.
(D) Western blot demonstrating the deletion
of the TACI protein from splenocytes.
Spleens from two 1/1 and 2/2 mice were
extracted in detergent and immunoprecipi-
tated with a rabbit polyclonal antibody
against the extracellular domain of mouse
TACI. The immunoprecipitates were then
subjected to Western blotting and probing
with the same anti-TACI antibody and peroxi-
dase-linked goat anti-rabbit, followed by che-
miluminescent detection (Amersham). The
TACI-specific bands are indicated with an
arrow. Cellular TACI protein frequently mi-
grates on SDS-PAGE as doublets at 37 and
42 kDa. This likely represents incomplete re-
duction of the disulfide bridges, which make
up the cysteine-rich domain of the receptor.
we have deleted the taci gene from mice and have found TACI null Mice Have Enlarged Spleens with Increased
a requirement for the protein in T-independent antibody Numbers of Mature Circulating and Splenic B Cells
production and in the regulation of B cell numbers. The spleens from immunologically naive TACI knockout
mice were larger in size and mass when compared with
those from their wild-type littermates (Figure 2A). Com-Results
paring the splenic lymphocytes, there were twice as
many B cells in the TACI null spleens, whereas the TTargeting the taci Locus
cell number remained the same (Figure 2B). Similarly,A genomic P1 clone containing the taci locus was ob-
there were approximately twice the number of B cellstained by PCR screening using oligonucleotides derived
present in peripheral blood of TACI knockout mice,from the murine taci cDNA (von Bulow et al., 2000). A
whereas the numbers of CD4 and CD8 T cells cellsreplacement targeting vector was constructed (Figure
did not signicantly differ when compared with littermate1A), and one allele from 129SVJ embryonic stem (ES)
controls (Figure 2C). To assess whether this increase incells was targeted as described in the Experimental
B cell numbers in the TACI null mice was due to in-Procedures section. Two strains of taci-targeted mice
creased B cell proliferation, BrdU uptake into B220-were derived from two independent ES clones and were
positive splenocytes was determined 24 hr after intra-maintained in parallel. In the results described below,
peritoneal injection. Enhanced incorporation of BrdUsimilar data were obtained from each strain. TACI knock-
into the TACI null splenic B cells (Figure 2D) indicatesout mice are viable, fertile, and, when bred and stored
that there was increased turnover of these cells in thein sterile housing for at least 6 months, have shown no
spleen, probably accounting for the increased B cellexternal defects. The deletion of the TACI protein in the
numbers observed both in the spleen and peripheralsplenocytes of targeted mice was confirmed by immu-
blood. These BrdU-positive cells were determined to benoprecipitation followed by Western blot with a mouse
IgD-high, thereby excluding the possibility of germinalTACI-specific polyclonal antibody (Figure 1D). A Men-
center cells contributing to the detected cycling popula-delian distribution of genotypes was observed on aver-
tion (data not shown). In the spleen, these cells appearedage for all matings (data not shown). Furthermore, in all
to accumulate as mature B cells (IgM-low, IgD-high) andthe data that follow, there was no significant difference
were not arrested in the transitional or marginal zonebetween wild-type and taci1/2 mice, indicating that a
single taci allele is sufficient for function. stages (Figure 2E).
Figure 2. TACI null Mice Have Enlarged Spleens and Increased Numbers of Mature B Cells
(A) Spleen mass in TACI null mice and littermate controls; the bar represents the mean value.
(B) Absolute numbers of B (B220-pos.) and T cells (CD3-pos.) recovered from spleens of wild-type and TACI null mice. The relative proportion
of B220 and CD3 cells was determined by flow cytometry and the numbers extrapolated from the total splenocyte count (N 5 5, bars; SEM; *,
p , 0.01).
(C) Absolute numbers of B and T lymphocytes in fresh blood from TACI null mice and littermate controls. The relative proportion of B220,
CD4, and CD8 cells was determined by flow cytometry and the numbers extrapolated from the lymphocyte value obtained from a full blood
count (N 5 5, bars; SEM; *, p , 0.01).
(D) Cell cycle turnover in splenocytes from naive mice. Mice were injected with BrdU 24 hr before sacrifice. Splenocytes were prepared,
stained with phycoerythrin-conjugated anti-B220 and FITC-conjugated anti-BrdU, followed by flow cytometry. Gates were set on forward and
side scatter as well as the B220/BrdU-positive events. Representative density plots for wild-type and TACI null mice are depicted at left. Axes
represent log fluorescence intensity. The proportions of B220-positive cells, which had incorporated BrdU within 24 hr from each mouse, are
depicted at right. The bar represents the mean of six mice in each cohort.
(E) Flow cytometric analysis demonstrating that the majority of B cells in spleens from TACI null mice are mature. Splenocytes were prepared
from naive normal and TACI null mice, stained with phycoerythrin-conjugated anti-IgM and FITC-conjugated anti-IgD, and then subjected to
flow cytometry. Depicted are data from a representative control (left) and TACI null (right) mouse from a cohort of five each. Immature B cells
and marginal zone cells are IgD-low and IgM-high (I), whereas the mature B cells are IgD-high and IgM-low (M). It can be seen for both control
and TACI null mice that the majority of splenic B cells are mature.
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TACI null Splenocytes Bind to and Show
a Proliferative Response to BlyS
Since the TACI knockout mice showed increased num-
bers of B cells, a phenotype paradoxically similar to
that of BLyS overexpression observed by others, we
predicted that TACI null splenocytes would proliferate
normally in response to BLyS. Tritiated thymidine up-
takes were determined in TACI null and control spleno-
cytes stimulated in vitro with recombinant human BLyS
in the presence of IL-4 and crosslinking anti-IgM anti-
bodies. The cells from TACI null mice were able to re-
spond to BLyS, and no significant difference was ob-
served when compared with cells from littermate
controls (Figure 3A). Binding of epitope-tagged recom-
binant BLyS to B220-positive splenocytes, determined
by flow cytometry (Figure 3B), showed no difference in
binding between B cells from TACI null mice and their
wild-type littermate controls. Binding of BLyS on spleno-
cytes is likely due to BCMA, which probably mediates
the proliferative response to the ligand.
TACI null Mice Exhibit Normal T-Dependent
Humoral Responses
Comparison of serum antibody titers from naive normal
and TACI mutant mice revealed a significant decrease
in IgM and IgA concentrations, although total IgG con-
centrations were comparable (Figure 4A). There were
no differences in the IgG1, IgG2a, IgG2b, and IgG3 isotypes
(data not shown), implying that the TACI null B cells can
undergo normal isotype switching. Following immuniza-
tion with the T-dependent antigen, keyhole limpet hemo-
cyanin (KLH), both TACI mutant and normal mice re-
sponded similarly, with KLH-specific IgM being secreted
by day 4 and IgG switching occurring by day 8. Serum
IgG concentrations increased and IgM concentrations
decreased with time (Figure 4B). Similar results were
obtained with another T-dependent antigen, NP-conju-
gated chicken g-globulin (NP-CgG) (data not shown).
We conclude that the T-dependent humoral response
is not impaired in TACI null mice.
Figure 3. TACI null Splenic B Cells Bind and Proliferate in Response
The T-Independent Type II Humoral Response to BlyS
Is Defective in TACI null Mice (A) Proliferative response to BLyS. Splenocytes were prepared from
Immunization with the T-independent type I antigen, NP- TACI null and littermate control mice. Cells were incubated for 72 hr
conjugated lipopolysaccharide, showed no significant with the indicated concentrations of human recombinant BLyS in
the presence of murine IL-4 and crosslinking goat anti-mouse IgM.difference in specific antibody secretion by TACI mutant
Tritiated thymidine incorporation was determined over the last 24and wild-type mice (data not shown). However, when
hr. Depicted data are from individual mice and are representativemice were immunized with the T-independent type II
of five animals in each cohort. Background counts in response to
(TI-II) antigen NP-ficoll, we observed a significant defect anti-IgM and IL-4 alone ranged from near 4000 to 6000 CPM within
in secretion of both specific IgM and IgG in the TACI each cohort of mice and were subtracted from the values depicted.
mutant mice in comparison with littermate controls (Fig- (B) Flow cytometric analysis of BLyS binding to splenic B cells. After
blocking Fc receptors, splenocytes were incubated in the presenceure 5A). NP-specific IgM secretion in the mutant mice
(gray line) and absence (black line) of soluble Flag epitope-taggedwas about one-third, and specific IgG secretion was
human recombinant BLyS (0.1 mg/106 cells). BLyS binding was de-about one-fifth, of the amount produced by littermate
tected with biotinylated anti-Flag M2 antibodies followed by incuba-
controls. This decrease in secretion was detected for tions with phycoerythrin-conjugated streptavidin. Depicted are rep-
all the IgG isotypes tested (Figure 5B). Increasing the resentative histograms showing BLyS staining obtained from normal
dose of NP-ficoll 10-fold to 50 mg per animal, as well (top panel) and TACI null (bottom panel) B220-positive splenocytes
(FL2-height, log fluorescence).as reducing it to 1mg, did not overcome the defect in
reponse by TACI null mice (data not shown). Deletion
of the taci gene induced a loss of 80% of the specific
antibody response to a second T-independent antigen,
Pneumovax, in comparison with their littermate controls
(Figure 5C).
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Figure 4. T-Dependent Humoral Responses
Are Normal in TACI null Mice
(A) Total serum immunoglobulins from 6-week-
old TACI null mice and littermate controls
measured by ELISA (n 5 5; *, P , 0.01).
(B) Humoral response to KLH, a T-dependent
antigen. Cohorts (n 5 5) of TACI null and lit-
termate control mice were immunized with 50
mg KLH, and blood was sampled on the days
indicated. Concentrations of KLH-specific
serum IgM (top panel) and IgG (bottom panel)
were detected by ELISA.
Splenic Architecture in TACI null Mice firmatory evidence that the MZ architecture is normal
in the TACI null mice and contains a myeloid componentThe different types of antibody responses occur in geo-
graphically distinct compartments within the spleen. To necessary for antigen presentation (Figure 6C). Further-
more, spleen sections from TACI null mice immunizedfurther investigate a possible failure of normal B cell
migration within the spleens of TACI null mice, we exam- with a T-dependent antigen, NP-conjugated chicken
g-globulin, showed normal germinal center formation asined splenic architecture. In spite of spleen enlargement,
with an increased B cell component in TACI null mice, evidenced by staining with peanut lectin (Figure 6D).
Others have demonstrated that B1 and marginal zonethe architecture of these spleens appeared normal. Im-
munofluorescent staining of spleen sections with anti- B (MZB) cells are essential for the TI-II humoral response
(Prior et al., 1994; Scher, 1982; Guinamard et al., 2000).bodies to B220 and CD3 indicated a similar arrangement
of T and B cells in the follicles when comparing wild- Since TACI null mice failed to respond normally to TI-II
antigens, we searched for the presence of these cellstype and TACI null spleens (Figure 6A). Staining of sec-
tions with IgM and IgD (Figure 6B) also showed similar in our mice. Relative numbers of B1 cells (B220- and
CD5-positive) were determined in blood, spleen, andarrangement of mature (IgD-high) B cells and marginal
zones (IgM-high). Further analysis of the marginal zone peritoneum, and no significant differences were ob-
served between cells from TACI null mice and their nor-(MZ) revealed the presence of MAdCAM-1-positive en-
dothelial reticular cells forming the follicular boundary mal littermates (Figure 7A). Marginal zone B cells (B220-
positive, CRI/CRII-positive, and CD23-negative) wereas well as CD11c-positive dendritic cells, providing con-
Figure 5. The T-Independent Type II Humoral
Response Is Defective in TACI null Mice
(A) Humoral response to NP-ficoll, a T-inde-
pendent type II antigen. Cohorts (n 5 5) of
TACI null and littermate control mice were
immunized with 5 mg NP-ficoll, and blood was
sampled on the dates indicated. Concentra-
tions of NP-specific IgM (top panel) and IgG
(bottom panel) were determined by ELISA (*,
p , 0.01).
(B) Distribution of IgG isotypes in sera from
TACI null and normal littermate mice after im-
munization with NP-ficoll. IgG1, IgG2a, IgG2b,
and IgG3 concentrations were determined by
ELISA from the day 14 sera of NP-ficoll-immu-
nized mice depicted in (A) (*, P , 0.01).
(C) IgM response to Pneumovax. Cohorts (n 5
5) of TACI mutant mice and littermate controls
were immunized with Pneumovax, and Pneu-
movax-specific serum IgM was determined
after a week.
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Figure 6. The Splenic Architecture of TACI
null Mice Is Normal
Confocal images showing immunofluores-
cent staining of wild-type (wt) and TACI mu-
tant (mut) spleen sections from naive mice
(A–C).
(A) Distribution of B and T cells. Staining for
B cells was with biotinylated anti-B220, fol-
lowed with Texas Red-conjugated streptavi-
din, for T cells with FITC-conjugated anti-
CD3. The white bars represent 10 mm.
(B) Marginal zone (arrows) and mature B cell
distribution. Sections were stained with bio-
tinylated anti-IgM, followed with Texas Red-
streptavidin, and FITC-conjugated anti-IgD.
(C) Marginal zone architecture showing the
MZ reticular endothelial cells and CD11c-pos-
itive dendritic cells. Sections were stained with
anti-MAdCAM-1, followed with rhodamine-
conjugated goat anti-rat IgG and FITC-conju-
gated anti-CD11c.
(D) Germinal center formation. Mice were
immunized with alum-precipitated chicken
g-globulin (50 mg). The animals were sacri-
ficed after 8 days and spleen sections were
stained with biotinylated peanut agglutinin fol-
lowed by Texas Red-streptavidin and counter-
stained with FITC-conjugated anti-B220.
also detected in similar proportions in spleens from nor- that TACI null mice have increased numbers of B cells,
in both spleen and peripheral circulation. This result wasmal and TACI null mice (Figure 7B). This indicates that
the cells required for a TI-II response are present in TACI unexpected because others have shown that BLyS, a
known ligand for both TACI and the homologous TNFRnull mice.
member BCMA, induces B cell proliferation. The sim-
plest explanation for these results is that TACI may ordi-Discussion
narily induce a growth inhibitory signal that is offset by
a proliferative signal induced by BCMA. Although bothThis report describes the first member of the TACI/BLyS
receptor-ligand family to be deleted in mice. We find receptors are thought to activate NF-kB, there is no
TACI Regulates T-Independent Humoral Immunity
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Figure 7. TACI null and Wild-Type Mice Have
Similar Proportions of B1 and Marginal Zone
B Cells
Depicted are representative results from four
mice in each cohort; differences are not sta-
tistically significant. (A) Flow cytometric anal-
ysis of B1 cells (B220 pos. and CD5 pos.)
derived from peripheral blood (PBL), spleno-
cytes, and peritoneum. (B) Flow cytometric
analysis of marginal zone cells from IgM-high
gated splenocytes. The MZ cell population
is B220-positive, CR1/CD2-high, and CD23-
negative, as indicated.
sequence homology within their intracellular domains maturation is not critically dependent upon TACI. We
cannot rule out at this point, however, a potential roleand there likely exist other second messengers that are
differentially activated by each. According to this model, for TACI in B cell proliferation that can be redundantly
provided by BCMA in this knockout mouse.B cell proliferation in TACI null mice is enhanced be-
cause of increased stimulation through BCMA, in the We have demonstrated a requirement for TACI in order
to mount a robust TI-II antibody response, whereas theabsence of its competitor, TACI. This notion will be ad-
dressed in the future by the generation of BCMA knock- T-dependent response does not depend on TACI. This
complements work by others showing that both CD40out mice.
Mice bearing a BLyS transgene show increased B cell (Castigli et al., 1994) and CD40L (Xu et al., 1994) knock-
out mice have defective T-dependent humoral immunitynumbers with an enriched population of B cells in the
spleen that accumulate at an immature stage of devel- but normal responses to T-independent antigens. We
hypothesize that these selective defects are a functionopment (Batten et al., 2000). Our mice demonstrated
normal maturation of B cells, thus indicating that B cell of the splenic architecture and access of B cells to
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CD40L-bearing T cells. The T-dependent response tive antibody response and may also provide a useful
takes place within splenic follicles, facilitating B cell animal model of immunodeficiency conditions in hu-
access to T cells of the periarteriolar lymphoid sheath mans in which B cells do not function appropriately in
(PALS), which is intact in taci2/2 spleens. T cells provide response to TI-II antigens.
costimulatory signals such as CD40L, which are re-
Experimental Proceduresquired for the B cell humoral response to T-dependent
antigens. On the other hand, B cells responding to
The Mayo Institutional Animal Care and Use Committee approved
T-independent type II antigens are largely extrafollicular, all animal protocols.
residing in the marginal zone. In the absence of a CD40
signal, these cells appear to require a TACI signal to Targeting the taci Locus
A murine P1 library (Genome Systems) was screened by PCR withmount a robust response. In the marginal zone, antigen
synthetic deoxyoligonucleotides (59-GGAAACGTGTAGCTTCTGC-39is presented directly to B cells by dendritic cells (Ban-
and 59-GTCATTCTCCATCTTTCTCGA-39) amplifying a 415 bp exonchereau and Steinman, 1998), and a costimulatory role
fragment from murine taci cDNA (von Bulow et al., 2000). The re-for BLyS (which is itself expressed by dendritic cells) in
sulting P1 clone was mapped by Southern blot using murine taci
this function has been suggested (Laabi and Strasser, cDNA fragments as probes. A targeting construct was cloned into
2000). Dendritic cells genetically modified to express pBluescript (Stratagene) in which an z4 kb fragment containing
CD40L have been shown to activate humoral immunity the first two exons (encoding the extracellular domain) of taci was
replaced with a neo cassette, and an HSV-TK cassette was insertedin the absence of T cells (Kikuchi et al., 2000). Further-
3.5 kb upstream of the targeted sequence (Figure 1A). The constructmore, it has been demonstrated in mice that the ordi-
was linearized and electroporated into murine embryonic stem (ES)narily poor humoral response to polysaccharides from
cells from 129SVJ mice (Genome Systems). ES cells were main-
S. pneumoniae can be augmented by administering anti- tained and drug selected on murine embryonic fibroblasts as de-
bodies that crosslink CD40, thereby mimicking T cells scribed (van Deursen et al., 1996). Drug-resistant ES clones were
in their absence (Dullforce et al., 1998). Since deletion screened for homologous recombination by Southern blot (Figure
1B). Correctly targeted ES clones were karyotyped, screenedof the TACI protein has no effect on the T-dependent
against mycoplasma, and injected into C57Bl/6 blastocysts (vanhumoral responses, it seems that CD40L presented by
Deursen et al., 1993), which were transferred to pseudopregnantT cells fulfills the costimulatory requirement and thereby
foster mothers to yield chimeric mice. Chimeric males were crossedallows B cell activation. We propose therefore that TACI with C57Bl/6 females, and agouti F1 offspring were screened for
is a functional homolog of CD40 able to costimulate B the targeted taci allele by PCR. Homozygous targeted mice were
cells in a similar manner in the absence of T cells in the derived by crossing F1 heterozygous mice and screening by PCR
and/or Southern blot (Figure 1C). The genetic background of themarginal zone. There are other parallels between CD40
resulting colony was equally 129SVJ and C57Bl/6. Deletion of theand TACI. Both are members of the TNFR family and
TACI protein was confirmed by immunoprecipitation from spleno-signal through binding of TRAF proteins to activate the
cyte lysates with mTACI-specific polyclonal antibodies, followed byNF-kB transcription factors (Baker and Reddy, 1998;
Western blot with the same antibodies.
von Bulow and Bram, 1997; Xia et al., 2000).
T-dependent humoral responses in the TACI null mice Immunizations
appeared normal. TACI null mice produced IgM in re- Mice (8 to 12 weeks of age) were inoculated intraperitoneally with
the following antigens diluted in phosphate buffered saline (PBS):sponse to KLH and CgG, demonstrated normal isotype
(4-hydroxy-nitrophenacetyl)-conjugated chicken g-globulin (NP-CgG,switching to produce IgG, and germinal center formation
Biosearch Technologies), keyhole limpet hemocyanin (KLH, Calbio-in the spleen. Numbers of T cells in peripheral blood
chem), NP-conjugated lipopolysaccharide from E. coli (NP-LPS, Bio-and in the spleen were also normal. Additionally, mixed
search Technologies), NP-conjugated ficoll (NP-ficoll, Biosearch
lymphocyte cultures showed a standard level of prolifer- Technologies), and a collection of capsular polysaccharide prepara-
ation of T cells derived from TACI null mice upon stimula- tions from 23 strains of S. pneumoniae (Pneumovax, Merck).
tion with irradiated allogeneic lymphocytes (data not
ELISAsshown), indicating normal functioning of T cells re-
High-capacity ELISA plates (Maxsorb, Nunc) were coated with 10sponding through MHC class II receptors. Although we
mg/ml goat anti-Ig (Southern Biotechnologies) for assay of totalpreviously observed TACI-specific staining of a subset
serum antibodies and standards; 10 mg/ml NP-conjugated bovineof in vitro-activated human peripheral T cells, it appears serum albumin (NP40-BSA, Biosearch Technologies) for the assay
that the deletion of TACI in mice has no critical effect of NP-specific haptens; both in 50 mM carbonate/bicarbonate (pH
on T-dependent functions in vivo. 9.2) for 1 hr at 378C; or 1 mg/ml Pneumovax in PBS overnight at 48C
Other knockout models that have led to a defective TI- for the assay of pneumococcus vaccine-specific antibodies. Plates
were blocked with 1% gelatin in PBS for 1 hr at room temperature,II response include mice lacking tyrosine kinase Pyk-2
washed with PBS 1 0.05% Tween 20 (PBS-T), and loaded with sera(Guinamard et al., 2000), Brutons tyrosine kinase (Btk)
serially diluted with 0.1% gelatin in PBS. After 30 min incubation at(Prior et al., 1994; Scher, 1982), and phospholipase C-g2
378C, plates were washed with PBS-T and incubated with alkaline
(Wang et al., 2000). The pyk22/2 mice lack marginal zone phosphatase-conjugated goat anti-mouse IgM, -total IgG, -IgG iso-
B cells, whereas the btk2/2 mice lack B1 cells, demon- types, or -IgA (Southern Biotechnologies). Following washes with
strating that MZB and B1 cells are required for a TI-II PBS-T, the substrate solution (80 mM 4-methylumbelliferyl phos-
response. The PLCg22/2 mice also have a B1 cell defi- phate in 1 M diethyl amine [pH 10]) was added and read on a
fluorescent plate reader (Wallac) after a 30 min incubation at roomciency and a block in B cell maturation at the pro-B
temperature. Data were quantified against appropriate purifiedstage. In contrast, TACI knockout mice have mature B
mouse immunoglobulin standards (Southern Biotechnologies).cells, MZB cells, and B1 cells, suggesting that, since
the required cells for a TI-II response are in place, the Flow Cytometry
humoral defect lies with the response of these cells. We Heparinized whole blood (100 ml) was treated with Fc-block (Phar-
believe the development of this mouse model will help mingen-Becton Dickinson) and incubated sequentially with the rele-
vant fluorochrome-conjugated antibodies (unless otherwise stated,to elucidate molecular events that contribute to an effec-
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all from Pharmingen-Becton Dickinson) at 0.5mg /100 ml in Hanks (2000). TACI and BCMA are receptors for a TNF homologue impli-
cated in B-cell autoimmune disease. Nature 404, 995–999.Balanced Salt Solution (HBSS) with 1% BSA. After the final staining
step, red blood cells were lysed and lymphocytes fixed with “FACS Guinamard, R., Okigaki, M., Schlessinger, J., and Ravetch, J.V.
lysis solution” (Becton Dickinson). Cells were analyzed on FACScan (2000). Absence of marginal zone B cells in Pyk-2-deficient mice
or FACScalibur flow cytometers using the “Cellquest” software defines their role in the humoral response. Nat. Immunol. 1, 31–36.
package (Becton Dickinson). Splenocytes were prepared using
Khare, S.D., Sarosi, I., Xia, X.Z., McCabe, S., Miner, K., Solovyev,standard protocols. For the measurement of BrdU incorporation,
I., Hawkins, N., Kelley, M., Chang, D., Van G., et al. (2000). Severemice were inoculated with 1 mg BrdU (Sigma) intraperitoneally 24
B cell hyperplasia and autoimmune disease in TALL-1 transgenichr prior to sacrifice. Splenocytes were prepared and stained with
mice. Proc. Natl. Acad. Sci. USA 97, 3370–3375.both B220 and BrdU antibodies using reagents from Pharmingen-
Kikuchi, T., Worgall, S., Singh, R., Moore, M.A., and Crystal, R.G.Becton Dickinson. To validate BrdU incorporation, thymocytes were
(2000). Dendritic cells genetically modified to express CD40 ligandalso prepared from the same animals. BrdU staining was verified in
and pulsed with antigen can initiate antigen-specific humoral immu-a range of 18% to 22% of CD3-positive thymocytes. No difference
nity independent of CD41 T cells. Nat. Med. 6, 1154–1159.was evident between wild-type and TACI null mice. BLyS binding
was determined by incubating splenocytes with Flag-tagged human Laabi, Y., and Strasser, A. (2000). Immunology. Lymphocyte sur-
recombinant BLyS (J. Gross, Zymogenetics, Inc.) at 100 ng /106 cells vival—ignorance is BLys. Science 289, 883–884.
in HBSS with 1% BSA. Following washes, cells were consecutively
Laman, J.D., Claassen, E., and Noelle, R.J. (1996). Functions of CD40
incubated with biotinylated anti-Flag antibodies (Sigma), phycoer-
and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16, 59–108.
ythrin-conjugated streptavidin (Jackson Immunoresearch), and
Mackay, F., Woodcock, S.A., Lawton, P., Ambrose, C., Baetscher,FITC-conjugated antibodies against B220.
M., Schneider, P., Tschopp, J., and Browning, J.L. (1999). Mice
transgenic for BAFF develop lymphocytic disorders along with auto-Immunofluorescence
immune manifestations. J. Exp. Med. 190, 1697–1710.Fresh spleens were frozen in tissue freezing medium (Triangle Bio-
Marsters, S.A., Yan, M., Pitti, R.M., Haas, P.E., Dixit, V.M., and Ash-medical Sciences), and 10 mm sections were prepared with a cryo-
kenazi, A. (2000). Interaction of the TNF homologues BLyS andstat (Leica). Sections were fixed in acetone and blocked with 1%
APRIL with the TNF receptor homologues BCMA and TACI. Curr.gelatin and 1% normal rat serum in PBS. Antibody and lectin incuba-
Biol. 10, 785–788.tions were in PBS with 0.1% gelatin as indicated on the figure
legends. Sections were washed with PBS between incubations, Moore, P.A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D.W., Feng,
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stimulator. Science 285, 260–263.
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